Carolina Regional Cancer Center Receives ACR Accreditation For Radiation Oncology
Submitted by: Fuel Interactive
2008-06-26 23:00:53
(OPENPRESS) June 27, 2008 -- Carolina Regional Cancer Center (CRCC) MUSC Hollings Cancer Center has been awarded a three-year term of accreditation in Radiation Oncology Services as the result of a comprehensive review by the American College of Radiology (ACR). The accreditation signifies that CRCC has met stringent, nationally accepted standards for radiation oncology facilities as established by the ACR. CRCC is the first facility and at present the only facility to be accredited by the ACR in the state of South Carolina.
The ACR, headquartered in Reston, Va., awards accreditation to facilities for the achievement of high practice standards after a peer-review evaluation of the practice. Evaluations are conducted by board-certified physicians and medical physicists who are experts in the field. They assess the qualification of the personnel and the adequacy of facility equipment. The surveyors report their findings to the ACR's Committee on Accreditation, which subsequently provides the practice with a comprehensive report.
"Being the first and only facility in the state to receive ACR accreditation in Radiation Oncology is a tribute to our strong commitment to providing the highest quality of care for our patients," said Steve Bass, MD, Medical Director. "The receiving of the ACR accreditation plus the upcoming addition of TomoTherapy to our treatment capabilities illustrates our commitment to patient care and our state of the art treatment technologies," continued Dr. Bass.
"The ACR Accreditation is a rigorous review process and validates that our facility meets nationally accepted standards of care. The accreditation demonstrates to patients, referring physicians, peers, regulatory agencies and payers our commitment to high standards for radiation therapy and quality assurance," added Patricia Price, RTT, Director of Clinical Operations.
CRCC and MUSC Hollings Cancer Center are continuing their joint efforts to broaden the local availability of state-of-the-art cancer treatments and quality patient care.
About Carolina Regional Cancer Center
Carolina Regional Cancer Center is a health care facility that provides comprehensive radiation treatment services. The Center has been providing high quality cancer care for over twenty-eight years. The state of the art center is located at 4708 Oleander Drive, Myrtle Beach, S.C. It is staffed by four physicians—R. Steve Bass, MD, Clinical Director, Assistant Clinical Professor of Radiation Oncology at Medical University of South Carolina and Vanderbilt University Medical Center trained, Todd Williams, MD, Assistant Clinical Professor of Radiation Oncology at MUSC, Paul G. Goetowski, MD, Associate Clinical Professor at Medical College of Georgia in Augusta and Assistant Clinical Professor at MUSC, and Stephen F. Andrews, D.O., Assistant Clinical Professor at MUSC and a graduate from the prestigious Fox Chase Cancer Center in Philadelphia. Dr. Bass also serves on the Hollings Cancer Citizens' Advisory Board. For additional information regarding CRCC, please see the website www.CRCCmd.com.
About the Hollings Cancer Center
Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques and has multidisciplinary clinics that involve surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and many other specialists seeing patients simultaneously under one roof. Multidisciplinary care is provided in disease specific clinics such as thoracic, breast, head & neck, genitourinary, gastrointestinal, hematologic, neuro, and pediatric cancers. In 2004 the HCC diagnosed and/or treated more than 1,947 new cancer patients, the largest cancer care provider in the state.
The Hollings Cancer Center is the largest academic-based cancer program in South Carolina. The Hollings Cancer Center is currently funded as a developing National Cancer Institute designated cancer center and has more than $33M in cancer research funding. More than 1,000 people are currently participating on a cancer clinical trial at Hollings.
MUSC Hollings Cancer Center has established the Clinical Trials Network to contract with private cancer care providers to further expand its clinical trial program. Network members are allowed access to MUSC HCC clinical trials; they are provided support for clinical trial operations, oversight and monitoring of the conduct of the trial. The Clinical Trials Network is a collaborative effort with private practices to broaden the reach of new research that may one day be the new standards of care.
About The American College of Radiology
The ACR is a national organization serving more than 32,000 diagnostic-interventional radiologists, radiation oncologists, and nuclear medicine and medial physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services.
